NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) recently announced a pivotal shift in its board with the appointment of Luba ...

Getting more effective drugs for patients in need as quickly as possible should be the ultimate reward and objective.

Many HCPs now place greater importance on pharmaceutical companies that integrate patients within the continuum of care.

Pharmaceutical companies must prioritize efforts to reach patients in underserved parts of the world with medicines such as insulin for diabetics and, crucially, measure the effectiveness of these ...

The 2024 Pharmacy Benefit Manager Customer Satisfaction Report published by Pharmaceutical Strategies Group ("PSG") disclosed ...

Marketing campaigns today need to foster curiosity and wonder with a keen focus on brand authenticity. Authenticity is ...

MEIP), a clinical-stage pharmaceutical company, announced that it is continuing to evaluate strategic alternatives to maximize shareholder value, including potential mergers and acquisitions or ...

We recently compiled a list of the 10 Best Japanese Stocks To Buy Now. In this article, we are going to take a look at where ...

Athira Pharma (ATHA) has received a new Hold rating ... with a Phase 2 trial anticipated to begin in 2025. This strategic pivot follows the disappointing outcome of the Phase 2/3 trial for ...

MEI Pharma, Inc. (Nasdaq: MEIP) (the "Company") today reported results for its fiscal year ended June 30, 2024.

SAN DIEGO - MEI Pharma, Inc. (NASDAQ:MEIP), a clinical-stage pharmaceutical company, announced that it is continuing to evaluate strategic alternatives to maximize shareholder value, including ...